1. Wang, Shuai, Zhou, Lingyi, Ji, Ning, Liu, Weishuai, Lu, Wei. 2023. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 69, 100976. doi:10.1016/j.drup.2023.100976. https://pubmed.ncbi.nlm.nih.gov/37210811/
2. Zhou, Lingyi, Fu, Zheng, Wang, Shuai, Lu, Wei, Yao, Zhi. 2022. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. In Frontiers in oncology, 12, 875097. doi:10.3389/fonc.2022.875097. https://pubmed.ncbi.nlm.nih.gov/35586489/
3. Ye, Zaisheng, Zheng, Miao, Zeng, Yi, Zheng, Qiuhong, Chen, Luchuan. 2021. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma. In Frontiers in oncology, 11, 612952. doi:10.3389/fonc.2021.612952. https://pubmed.ncbi.nlm.nih.gov/34235071/
4. Wang, Yanhui, Xian, Huimin. 2022. Identifying Genes Related to Acute Myocardial Infarction Based on Network Control Capability. In Genes, 13, . doi:10.3390/genes13071238. https://pubmed.ncbi.nlm.nih.gov/35886020/
智鼠故事 
